Training in STIs and infections of global health significance
Project Number5T32AI007637-19
Contact PI/Project LeaderWOOLS-KALOUSTIAN, KARA KAY
Awardee OrganizationINDIANA UNIVERSITY INDIANAPOLIS
Description
Abstract Text
PROJECT SUMMARY/ ABSTRACT
This is the third competitive renewal of this Institutional National Research Service Award (T32 AI07637) that
was previously entitled “Training in Sexually Transmitted Diseases Including HIV”. With this application we are
expanding in the breadth of pathogens addressed which has resulted in a change of the title to “Training in
STIs and Other Infections of Global Health Significance” (TSTI-OIGHS). The program proposes to train 3 post-
doctoral Trainees (MD and PhD) per year. The primary mission of this multidisciplinary training program
remains the training of well qualified MD and PhD scientists for productive and sustainable careers in research.
With increasing globalization it is imperative that we develop investigators who have the tools necessary to
develop prevention and treatment strategies directed at infections of global health significance. This requires
individuals trained in the spectrum of research skills ranging from the bench to the field. The foundation of the
TSTI-OIGHS is practical training in Molecular Biology, Immunology, Clinical Trials Design, Biostatistics,
Behavioral Science, Global Health, Epidemiology and Implementation Science within established and
productive research programs. Formal didactic training through the Career development, Education and
Research Training (CERT) Center affiliated with the Indiana Clinical and Translational Sciences Institute
(CTSI) and the Richard M. Fairbanks School of Public Health at IUPUI complements the practical training. This
training program draws on the skills of 17 full faculty mentors and 11 resource faculty from six Departments for
training our fellows. Training within the TSTI-OIGHS is structure around three tracks: 1) Basic Science, 2)
Behavioral and Clinical Science and 3) Global Health, Epidemiology and Implementation Science. As team
science is rapidly becoming the primary mode of operation for biomedical scientists addressing complex
questions related to human health, our training particularly emphases training investigators who are familiar
with the practices, procedures, and languages of collaboration necessary for creating and working within a
productive scientific team. This training program leverages the infrastructure and expertise of the Indiana
University Center for Global Health which supports the Academic Model of Access to Healthcare (AMPATH) in
western Kenya, a partnership that has been recognized as a model for international collaboration by the NIH.
Of the 12 fellows graduating from this program since 2006, 83% remain in academic medicine and/or research.
One third of graduated fellows old positions outside of Indiana University School of Medicine. In addition, this
training grant is a highly valued pipeline for Indiana University School of Medicine Faculty. All of these factors
make Indiana University an ideal place to train the next generation of experts in infectious of global health
significance.
Public Health Relevance Statement
PROJECT NARRATIVE
Infections such as HIV, Malaria, Hepatitis B, Human Papillomavirus and others are responsible for morbidity
and mortality in millions of individuals annually. With increasing globalization it
is imperative that we develop
investigators who have the tools necessary to develop prevention and treatment strategies directed at
infections of global health significance. The Indiana University School of Medicine provides state-of-the-art
research training for MD and PhD scientists with a bench to field focus designed to train the next generation of
expert researchers in infectious of global health significance.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
603007902
UEI
SHHBRBAPSM35
DKNHLK3NBPH7
DL9MTNNKWYR9
GY8GKRUWM7D5
HA48EWMJFV47
HCNBFNDANNV5
HCRDU7BNPZ13
HCWTYJ7KQ4U6
HEBLAL94JHP7
NKCRSKVJBXE3
TA1NYNZ27LQ7
WJJRCLJ936C8
X51WYC1QEPD7
XNBJV454V2W1
YCJNP5NJYCY1
YW8WNKKANDR9
625168166
N/A
Project Start Date
01-July-2001
Project End Date
31-August-2021
Budget Start Date
01-September-2019
Budget End Date
31-August-2020
Project Funding Information for 2019
Total Funding
$196,656
Direct Costs
$206,310
Indirect Costs
$15,425
Year
Funding IC
FY Total Cost by IC
2019
National Institute of Allergy and Infectious Diseases
$196,656
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32AI007637-19
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32AI007637-19
Patents
No Patents information available for 5T32AI007637-19
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32AI007637-19
Clinical Studies
No Clinical Studies information available for 5T32AI007637-19
News and More
Related News Releases
No news release information available for 5T32AI007637-19
History
No Historical information available for 5T32AI007637-19
Similar Projects
No Similar Projects information available for 5T32AI007637-19